Bioflux® provides real-time active monitoring – 24/7!
Bioflux® is a high-precision, single-unit mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of your ambulatory patients’ ECG information. The Bioflux® system is a complete solution for remote cardiac monitoring that merges seamlessly with physicians’ existing platforms and workflows.
We track over 100 billion heartbeats a year, monitored in real-time by our certified cardiac technicians with unmatched reporting capabilities.
How To Videos
01 Bioflux Contents
About bioflux device and its accessories
Clinical portal
You asked and we listened!
The Bioflux® online portal was designed by clinicians for clinicians.
After speaking with our healthcare professionals, we integrated their most desired features.
USER-FRIENDLY
Intuitive online portal design
CUSTOMIZED
Report views organized
by type & priority
MOBILE ACCESS
Secure on-the-go access,
on your PC, mobile and tablet
CONVENIENT
Integrated access to all reports
ONLINE CHAT
Support for expedited service
Our device features
Device
A 4 in 1 device with an
integrated cellular
modem
FDA
Our proprietary, FDA-cleared
software featuring advanced beat
& arrhythmia autodetection for
increased clinical yield
Remote
Monitoring & recording
3 channels of remote ECG data
for up to 30 days
Easy
Easily programmable auto-triggers
on bradycardia, tachycardia,
asystole, and atrial fibrillation
Diary
An integrated patient symptom
diary for manual events
One-Button
Single-button, integrated
touchscreen, ease of use –
encourages patient adherence
1000 Samples
A monitoring rate of up to 1000
samples per second provides
unparalleled clinical precision
Encrypted
Encrypted data & secure
reporting system to ensure
patient confidentiality
24/7
24/7 Call Center
available for all patient
questions or concerns
3 Channel
3 Channel Vectorswap can
remotely switch channels
for a better trace
30 day
Up to 30-day
wear duration
Real-Time
Leveraging cellular IoT
connectivity
Revolutionary technologies
How it works
Actively monitors & analyzes a patient’s ECG data in real time
Continuously collects & automatically transmits data to our secure cloud
Uses state of the art analysis, providing customized reports for each healthcare provider
Real time reporting improves physician workflow & reduces the time for patient diagnosis
Bioflux®—answering the need forimproved cardiac monitoring1
Great progress has been made in the treatment of cardiovascular disease (CVD). And yet, CVD is listed as the underlying cause of the deaths of more than 800,000 people in the US each year. That’s about one death every 40 seconds. That far exceeds the toll of all types of cancer combined. In fact, almost a third of all deaths in the US each year—from all causes—are attributable to CVD.
An estimated 85.6 million Americans, or 35% of the country’s population, suffer from one or more types of CVD. Contrary to stereotypes, only about half are over the age of 60, and the numbers of men and women are roughly equal.
US adults with at least one chronic disease
Fraction of American adults with CVD who are under 60
Fraction of American adults with CVD who are female
Making matters worse, the costs imposed by CVD on severely over-burdened healthcare systems are staggering. Annual health expenditures in the US linked to coronary heart disease and congestive heart failure total more than $200 billion per year. The American Heart Association predicts that number will almost double by 2030.
To maximize the benefits of advances in medical treatment, technology is needed that will help physicians diagnose cardiovascular diseases both precisely and early in their development. Biotricity is answering that call with Bioflux®.